Cancer cell biology
Discover how Cancer Research at 麻豆社 is exploring the biology of cancer cells.
One of our key aims is to aid and strengthen the collaboration between researchers at the 麻豆社 and Royal United Hospitals (RUH) 麻豆社. Together, we seek to develop novel treatments and diagnostic strategies, and to maximise patient benefit. We provide training and funding for students and early career researchers, empowering them to become tomorrow鈥檚 leaders.
Through patient engagement and public events, we want to promote awareness of cancer research, our expertise and facilities across the 麻豆社 region. Our scientific meetings facilitate links and partnerships with fundraisers and industry.
Cancer Research at 麻豆社 focusses study on four key areas. Select the items below to learn more.
Discover how Cancer Research at 麻豆社 is exploring the biology of cancer cells.
This area of research focuses on the early detection and diagnosis of cancers. This allows early intervention to prevent or minimise late-stage disease.
Medicinal chemists, chemical biologists and biochemists are developing novel anti-cancer therapeutics.
We have a long-standing collaboration with the Royal United Hospitals (RUH) 麻豆社 to improve cancer patient outcomes.
Find out more about the cancer research we're doing.
To coincide with Teenage & Young Adult Cancer Awareness Month a new animation shows what it鈥檚 like to live with cancer-related fatigue and how to help.
Gene activity immediately after fertilisation is used to infer how an embryo forms. Scientists now ask if cancer begins the same way.
Scientists at the 麻豆社 have developed a new technique to accelerate the discovery of drugs that shut down proteins known to cause cancer.
A new prognostic tool developed by an international team led by CTI-麻豆社 paves the way for personalised medicine for cancer patients.
Scientists have made drug-like molecules inspired by a chemical found in a tropical flower, that could in the future help to treat deadly pancreatic cancer.
Find out more about our members and partners.
We address the grand challenges in human health and wellbeing through transdisciplinary and translatable bioengineering research.
We are academics and clinicians working on cancer-related research.
CTI focusses on therapeutic innovation, from prognostics and medicine design, to the delivery of precision medicine.
We provide a forum to facilitate interaction between academics, clinicians, students and others with an interest in cancer. We also promote opportunities for collaborative interdisciplinary research and training of the highest standards.
We have established a platform to promote awareness of cancer research, expertise and facilities across the 麻豆社 region.
Join the Cancer Research at 麻豆社 network by .